Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population (Q46587223)
Jump to navigation
Jump to search
scientific article published on 7 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population |
scientific article published on 7 July 2005 |
Statements
1 reference
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population (English)
1 reference
B Fagerberg
1 reference
S Edwards
1 reference
T Halmos
1 reference
J Lopatynski
1 reference
H Schuster
1 reference
S Stender
1 reference
G Stoa-Birketvedt
1 reference
S Tonstad
1 reference
S Halldórsdóttir
1 reference
I Gause-Nilsson
1 reference
7 July 2005
1 reference
1 reference
48
1 reference
1716-1725
1 reference
9
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference